Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05467891
Title Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oana Danciu
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois Cancer Center Recruiting Chicago Illinois 60612 United States Details
Parkview Research Center Recruiting Fort Wayne Indiana 46845 United States Details
University of Michigan Health System Recruiting Ann Arbor Michigan 48109 United States Details
University of Michigan Health-West Recruiting Wyoming Michigan 49519 United States Details
New York University Clinical Cancer Center Recruiting New York New York 10016 United States Details
University of Wisconsin Recruiting Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from for the field